Abul-Husn, N., Bushlin, I., Morón, J.A., Jenkins, S.L., Dolios, G., Wang, R., Iyengar, R., Ma'ayan A. and Devi, L.A. Systems approach to explore components and interactions in the presynapse. Proteomics. 2009 Jun 27;9(12):3003-3315
Ferre, S., Baler, R., Bouvier, M., Caron, M.G., Devi, L.A. , Durroux, T., Fuxe, K., George, S.R., Javitch, J.A., Lohse, M.J., Mackie, K., Milligan, G., Pfleger, K.D., Pin, J-P., Volkow, N.D., Waldohoer, M., Woods, A.S., and Franco, R. Building a new conceptual framework fo receptor heteromers. Nature Chem. Biol. 2009; 5:131-134
Ellgren M, Artmann A, Tkalych O, Gupta A, Hansen HS, Hansen SH, Devi LA , Hurd YL. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol. 2008 Nov;18(11):826-34
Decaillot, F. M., Rozenfeld, R., Gupta, A., and Devi, L.A. Cell Surface Targeting of mu-delta Opioid Receptor Heterodimers by RTP4. Proc. Natl. Acad. Sci. USA, 2008;105:16045-50
Gagnidze K, Sachchidanand, Rozenfeld R, Mezei M, Zhou MM, Devi LA. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2. J Med Chem. 2008 Jun 26;51(12):3378-87.
Charlton JJ, Allen PB, Psifogeorgou K, Chakravarty S, Gomes I, Neve RL, Devi LA, Greengard P, Nestler EJ, Zachariou V. Multiple actions of spinophilin regulate mu opioid receptor function. Neuron. 2008 Apr 24;58(2):238-47.
Jenkins SL, Iyengar R, Diverse-Pierluissi MA, Chan AM, Devi LA, Sobie EA, Ting AT, Weinstein DC. Teaching resources. Using web-based discussion forums as a model of the peer-review process and a tool for assessment. Sci Signal. 2008;1(9):tr2.
Iyengar R, Diverse-Pierluissi MA, Jenkins SL, Chan AM, Devi LA, Sobie EA, Ting AT, Weinstein DC. Inquiry learning. Integrating content detail and critical reasoning by peer review. Science. 2008 Feb 29;319(5867):1189-90.
Gupta A, Rozenfeld R, Gomes I, Raehal KM, Décaillot FM, Bohn LM, Devi LA. Post-activation-mediated changes in opioid receptors detected by N-terminal antibodies. J Biol Chem. 2008 Apr 18;283(16):10735-44.
Heimann AS, Gomes I, Dale CS, Pagano RL, Gupta A, de Souza LL, Luchessi AD, Castro LM, Giorgi R, Rioli V, Ferro ES, Devi LA. Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20588-93.
Rozenfeld R, Abul-Husn NS, Gomez I, Devi LA. An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. ScientificWorldJournal. 2007 Nov 2;7:64-73. Review.
Morón JA, Devi LA. Use of proteomics for the identification of novel drug targets in brain diseases. J Neurochem. 2007 Jul;102(2):306-15.
Rozenfeld R, Devi LA. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J. 2007 Aug;21(10):2455-65.
Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol. 2007 May;71(5):1222-32.
Harkany T, Guzmán M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci. 2007 Feb;28(2):83-92.
Gupta A, Décaillot FM, Gomes I, Tkalych O, Heimann AS, Ferro ES, Devi LA. Conformation state-sensitive antibodies to G-protein-coupled receptors. J Biol Chem. 2007 Feb 23;282(8):5116-24.
Gendron L, Esdaile MJ, Mennicken F, Pan H, O'Donnell D, Vincent JP, Devi LA, Cahill CM, Stroh T, Beaudet A. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. Neuroscience. 2007 Jan 5;144(1):263-74.
Morón JA, Abul-Husn NS, Rozenfeld R, Dolios G, Wang R, Devi LA. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol Cell Proteomics. 2007 Jan;6(1):29-42.
Gupta A, Devi LA. The use of receptor-specific antibodies to study G-protein-coupled receptors. Mt Sinai J Med. 2006 Jul;73 (4):673-81.
Decaillot FM, Che FY, Fricker LD, Devi LA . Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration. J Mol Neurosci. 2006;28(3):277-84.
Gupta A, Decaillot FM, Devi LA . Targeting opioid receptor heterodimers: strategies for screening and drug development. AAPS J. 2006 Mar 10;8(1):E153-9.
Pignatari GC, Rozenfeld R, Ferro ES, Oliveira L, Paiva AC, Devi LA . A role for transmembrane domains V and VI in ligand binding and maturation of the angiotensin II AT1 receptor. Biol Chem. 2006 Mar;387(3):269-76.
He JC, Gomes I, Nguyen T, Jayaram G, Ram PT, Devi LA , Iyengar R. The G{alpha}o/i-coupled Cannabinoid Receptor-mediated Neurite Outgrowth Involves Rap Regulation of Src and Stat3. J Biol Chem. 2005 Sep 30; 280(39):33426-34.
Fricker AD, Rios C, Devi LA , Gomes I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Res Mol Brain Res. 2005 Aug 18; 138(2):228-35.
Pan H, Nanno D, Che FY, Zhu X, Salton SR, Steiner DF, Fricker LD, Devi LA . Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry. 2005 Mar 29; 44(12):4939-48.
Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Bivona TG, Philips MR, Devi LA , Iyengar R. Cannabinoid receptor induced neurite outgrowth is mediated by Rap1 activation through Galphao/I-triggered proteasomal degradation of Rap1GAPIL. J Biol Chem 2005 Mar 25;280(12):11413-21.
Taylor C, Fricker AD, Devi LA , Gomes I. Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways. Cell Signal 2005 May; 17(5):549-57.
Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA . A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia Proc Natl Acad Sci. 2004; 101:5135-5139.
Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA . Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol. 2003; 64:1317-1324.
Gomes I, Filipovska J, Devi LA . Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Methods Mol Med. 2003;84:157-83.
Mzhavia N, Pan H, Che FY, Fricker LD, Devi LA . Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. J Biol Chem. 2003 Apr 25;278(17):14704-11.
Gomes I, Filipovska J, Jordan B, Devi LA . Oligomerization of opioid receptors. Methods 2002 Aug;27(4):358-65.
Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA , Fricker LD. Processing of proSAAS in neuroendocrine cell lines. Biochem J. 2002;361:67-76.
Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA . Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci. 2001;98:343-348.
Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA , Fricker LD. Processing of proSAAS in neuroendocrine cell lines. Biochem J. 2002;361:67-76.
Devi LA . Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. TIPS 2001;22:532-537.
Berman Y, Mzhavia N, Polonskaia A, Devi LA . Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice. J Biol Chem. 2001;276:1466-1473.
Che FY, Yan L, Li H, Mzhavia N, Devi LA , Fricker LD. Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) mice. Proc Natl Acad Sci. 2001;9:9971-9976.
Mzhavia M, Berman Y, Che FY, Fricker LD, Devi LA . ProSAAS processing in mouse brain and pituitary. J Biol Chem 2001;276:6207-6213.
Gomes I, Jordan BA, Nagy V, Trapaidze N, Gupta A, Devi LA . Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 2000;20:RC110.
Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA , Douglass J. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 2000;20:639-648.
Jordan BA, Devi LA . G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999;5:697-700.
